SMAIO SA (ALSMA.PA) Stock Price & Overview

EPA:ALSMA • FR0014005I80

Current stock price

7.1 EUR
-0.2 (-2.74%)
Last:

The current stock price of ALSMA.PA is 7.1 EUR. Today ALSMA.PA is down by -2.74%. In the past month the price increased by 5.97%. In the past year, price increased by 105.8%.

ALSMA.PA Key Statistics

52-Week Range3.36 - 8.7
Current ALSMA.PA stock price positioned within its 52-week range.
1-Month Range6.65 - 7.3
Current ALSMA.PA stock price positioned within its 1-month range.
Market Cap
43.736M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.35
Dividend Yield
N/A

ALSMA.PA Stock Performance

Today
-2.74%
1 Week
-2.07%
1 Month
+5.97%
3 Months
+8.40%
Longer-term
6 Months +8.40%
1 Year +105.80%
2 Years +129.03%
3 Years +105.20%
5 Years N/A
10 Years N/A

ALSMA.PA Stock Chart

SMAIO SA / ALSMA Daily stock chart

ALSMA.PA Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to ALSMA.PA. When comparing the yearly performance of all stocks, ALSMA.PA is one of the better performing stocks in the market, outperforming 97.37% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

ALSMA.PA Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to ALSMA.PA. ALSMA.PA scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

ALSMA.PA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
PeriodQ2 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise %

ALSMA.PA Forecast & Estimates

10 analysts have analysed ALSMA.PA and the average price target is 8.67 EUR. This implies a price increase of 22.11% is expected in the next year compared to the current price of 7.1.

For the next year, analysts expect an EPS growth of 35% and a revenue growth 67.27% for ALSMA.PA


Analysts
Analysts86
Price Target8.67 (22.11%)
EPS Next Y35%
Revenue Next Year67.27%

ALSMA.PA Groups

Sector & Classification

Index Membership

ALSMA.PA Financial Highlights

Over the last trailing twelve months ALSMA.PA reported a non-GAAP Earnings per Share(EPS) of -0.35. The EPS increased by 36.05% compared to the year before.


Income Statements
Revenue(TTM)8.28M
Net Income(TTM)-1.85M
Industry RankSector Rank
PM (TTM) N/A
ROA -13.39%
ROE -25%
Debt/Equity 0.33
Chartmill High Growth Momentum
EPS Q2Q%43.48%
Sales Q2Q%126.03%
EPS 1Y (TTM)36.05%
Revenue 1Y (TTM)130.31%

ALSMA.PA Ownership

Ownership
Inst OwnersN/A
Shares6.16M
Float1.65M
Ins Owners65.36%
Short Float %N/A
Short RatioN/A

About ALSMA.PA

Company Profile

ALSMA logo image S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.

Company Info

IPO: 2022-04-06

SMAIO SA

2 Place Berthe Morisot, Parc Technologique

Saint-Priest AUVERGNE-RHONE-ALPES FR

Employees: 41

ALSMA Company Website

ALSMA Investor Relations

Phone: 33469842302

SMAIO SA / ALSMA.PA FAQ

What does ALSMA do?

S.M.A.I.O SA engages in the design, manufacture, and distribution of medical devices for the treatment of spinal pathologies. The company is headquartered in Saint-Priest, Auvergne-Rhone-Alpes. The company went IPO on 2022-04-06. The firm provides control on a surgical procedure to spine physician through a wide range of solutions like surgical plan/ i-plan, surgical procedure i-perform, outcome data/ i-check, and education/ i-learn. The company operates with the clinical data and imaging for specialists in spine surgery for transformation of the vertebral fusion. The company also offers spine surgeons a complete solution, consisting of software, implantable devices, associated services, and treat spinal pathologies requiring surgery. The company includes Kheiron Spinal Fixation System, a device that incorporates many implants, intended for the immobilization and stabilization of spinal segments as an adjunct to fusion of the thoracic, lumbar and/or sacral spine. The company also develops the Keops and Balance Analyzer 3D surgical planning and patient database management software.


Can you provide the latest stock price for SMAIO SA?

The current stock price of ALSMA.PA is 7.1 EUR. The price decreased by -2.74% in the last trading session.


Does ALSMA stock pay dividends?

ALSMA.PA does not pay a dividend.


What is the ChartMill technical and fundamental rating of ALSMA stock?

ALSMA.PA has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


Can you provide the sector and industry classification for SMAIO SA?

SMAIO SA (ALSMA.PA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the employee count for ALSMA stock?

SMAIO SA (ALSMA.PA) currently has 41 employees.


Can you provide the market cap for SMAIO SA?

SMAIO SA (ALSMA.PA) has a market capitalization of 43.74M EUR. This makes ALSMA.PA a Nano Cap stock.